TABRECTA Safety, Dosing, and Administration Guide
This brochure highlights the TABRECTA® (capmatinib) tablets safety profile and offers guidance on dose modifications. An informational sheet for patients with important reminders about administration and side effects is also included.
Patient Support Resources Brochure
Learn how Novartis can help support your patients with mNSCLC.
Patient Resources
Treatment With TABRECTA Patient Brochure
A comprehensive resource to prepare patients for their treatment journey with TABRECTA® (capmatinib) tablets.
More patient resources are available at TABRECTA.com